Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Adam Havey currently holds 174,398 shares of Emergent BioSolutions Inc. (EBS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Adam Havey has been a net seller of EBS stock. They have purchased $2.7K and sold $13.1M worth of shares.
Adam Havey's most recent insider trade was on Jun 9, 2023, when they sold 49,231 shares at $0.00 per share.
Adam Havey serves as Executive at Emergent BioSolutions Inc. (EBS). They have executed 129 insider transactions totaling $13.1M over their tenure at the company.
Adam Havey holds the position of Executive at Emergent BioSolutions Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 15 years and currently hold a stake valued at $0.
Adam Havey has shown a selling trading pattern, with $2.7K in total purchases and $13.1M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Adam Havey was on Mar 1, 2021, when they sold $2.0M worth of EBS shares. This transaction involved 20,145 shares at $99.02 per share.
Adam Havey currently owns 174,398 shares of Emergent BioSolutions Inc. (EBS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Adam Havey's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Adam Havey has 129 Form 4 filings on record as an insider at Emergent BioSolutions Inc..
Set alerts for Adam Havey and 40,000+ other insiders.